Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fenofibrate
Therapeutic Area : Neurology
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 04, 2024
Lead Product(s) : Fenofibrate
Therapeutic Area : Neurology
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenofibrate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lupin Launches Authorized Generic Version of Antara® in the United States
Details : Fenofibrate reduce elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides and apolopoprotein B to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hypercholesterolemia.
Product Name : Fenofibrate-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 11, 2021
Lead Product(s) : Fenofibrate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenofibrate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Barzilai Medical Center | Rambam Health Care Campus | Nazareth Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Fenofibrate for Patients With COVID-19 Requiring Hospitalization
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 10, 2020
Lead Product(s) : Fenofibrate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Barzilai Medical Center | Rambam Health Care Campus | Nazareth Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenofibrate
Therapeutic Area : Ophthalmology
Study Phase : Phase III
Sponsor : National Institutes of Health | National Eye Institute | Juvenile Diabetes Research Foundation | F. Hoffmann-La Roche | Helmsley Charitable Trust
Deal Size : Inapplicable
Deal Type : Inapplicable
Fenofibrate for Prevention of DR Worsening
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 10, 2020
Lead Product(s) : Fenofibrate
Therapeutic Area : Ophthalmology
Highest Development Status : Phase III
Sponsor : National Institutes of Health | National Eye Institute | Juvenile Diabetes Research Foundation | F. Hoffmann-La Roche | Helmsley Charitable Trust
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenofibrate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Hebrew U: Drug Could Turn Covid-19 Into Common Cold
Details : In the researchers' study in the Hebrew University's MicroTissue Lab, Fenofibrate was found to be effective in treating infected human tissue. Its effectiveness will now have to be proven in human clinical trials.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 15, 2020
Lead Product(s) : Fenofibrate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenofibrate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 14, 2019
Lead Product(s) : Fenofibrate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenofibrate
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 07, 2018
Lead Product(s) : Fenofibrate
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenofibrate
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 03, 2014
Lead Product(s) : Fenofibrate
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenofibrate
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 03, 2014
Lead Product(s) : Fenofibrate
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenofibrate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
CKD-337 Drug Interaction Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 19, 2014
Lead Product(s) : Fenofibrate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable